HBIO
NASDAQ
US
Harvard Bioscience, Inc. - Common Stock
$5.20
▲ +$0.11
(+2.16%)
Vol 31K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$29.8M
ROE
-199.4%
Margin
-61.6%
D/E
241.45
Beta
1.53
52W
$0–$2
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
75.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%
Next Report
May 11, 2026
EPS Estimate: $-0.62
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.62 | — | — |
| Dec 2025 | $0.36 | $0.00 | $-0.36 |
| Sep 2025 | $0.05 | $0.00 | $-0.05 |
| Jun 2025 | $-0.10 | $-0.10 | +$0.00 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | $22.0M | $24.6M | $21.8M | $20.4M | $20.6M | — |
| Net Income | -$4.8M | $18K | -$50.3M | -$2.3M | -$1.2M | — |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -144.2% | -144.2% | -144.2% | -144.2% | -199.4% | -199.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -11.2% | -64.7% | -64.7% | -64.7% | -61.6% | -61.6% |
| Gross Margin | 56.4% | 56.9% | 56.9% | 56.9% | 56.9% | 56.9% |
| D/E Ratio | 221.60 | 221.60 | 221.60 | 221.60 | 241.45 | 241.45 |
| Current Ratio | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 |
Key Ratios
ROA (TTM)
-59.1%
P/S (TTM)
0.34
P/B
1.5
EPS (TTM)
$-1.22
CF/Share
$0.09
Rev Growth 3Y
-7.5%
52W High
$2.28
52W Low
$0.28
$0.28
52-Week Range
$2.28
Financial Health
Free Cash Flow
$736K
Net Debt
$36.0M
Cash
$6.8M
Total Debt
$42.8M
As of Sep 30, 2025
How does HBIO compare to Life Sciences Tools & Services peers?
Peer group: Micro-cap Life Sciences Tools & Services (All) · 44 companies
HBIO valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Undervalued
P/S ratio
0.3
▼
91%
below
peers
(3.7)
vs Peers
vs Industry
Undervalued
P/B ratio
1.5
▼
26%
below
peers
(2.0)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
HBIO profitability vs Life Sciences Tools & Services peers
ROE
-199.4%
▼
708%
below
peers
(-24.7%)
vs Peers
vs Industry
Weak
Net margin
-61.6%
▼
121%
below
peers
(-27.8%)
vs Peers
vs Industry
Below avg
Gross margin
56.9%
▲
18%
above
peers
(48.2%)
vs Peers
vs Industry
Below avg
ROA
-59.1%
▼
306%
below
peers
(-14.6%)
vs Peers
vs Industry
Weak
HBIO financial health vs Life Sciences Tools & Services peers
D/E ratio
241.5
▲
943%
above
peers
(23.2)
vs Peers
vs Industry
High debt
Current ratio
0.8
▼
76%
below
peers
(3.3)
vs Peers
vs Industry
Low liquidity
Beta
1.5
▲
11%
above
peers
(1.4)
vs Peers
vs Industry
Less volatile
HBIO fundamentals radar
HBIO
Peer median
Industry
HBIO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
HBIO vs peers: key metrics
Top Holders
Top 5: 20.62%Weber Capital Management LL…
7.16%
$1.6M
Vanguard Group Inc
4.30%
$933K
Acadian Asset Management. L…
3.96%
$860K
Meros Investment Management…
2.72%
$591K
Corsair Capital Management,…
2.48%
$538K
As of Dec 31, 2025
Latest News
No related news yet